Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

North America Narcolepsy Drug Market 2017 - Jazz Pharmaceuticals

Invant Research
Posted on: 27 Jul 17

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse.

Scope of the Report:
This report focuses on the Narcolepsy Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Jazz Pharmaceuticals 
Teva Pharmaceutical

Market Segment by Countries, covering
United States

Market Segment by Type, covers
Antioxidants Type
Stimulants Type

Market Segment by Applications, can be divided into
Daytime Extreme Sleepiness

If you want a sample visit

For More Information about Narcolepsy Drug Market kindly mail on

Editor's Details

Roxanna Bell

Last updated on: 27/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.